BioCentury
ARTICLE | Clinical News

Betatropin Phase II diabetes data

September 11, 2001 7:00 AM UTC

Restoragen (Lincoln, Neb.) said subcutaneous infusion of its Betatropin recombinant glucagon-like peptide-1 improved blood glucose levels in type 2 diabetics over a 7 day infusion period compared to p...